Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.1.9
Consolidated Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
OPERATING EXPENSES    
Research and development $ 5,175,520us-gaap_ResearchAndDevelopmentExpense $ 1,761,486us-gaap_ResearchAndDevelopmentExpense
General and administrative 5,289,479us-gaap_GeneralAndAdministrativeExpense 1,950,953us-gaap_GeneralAndAdministrativeExpense
Total Operating Expenses 10,464,999us-gaap_OperatingExpenses 3,712,439us-gaap_OperatingExpenses
Loss from Operations (10,464,999)us-gaap_OperatingIncomeLoss (3,712,439)us-gaap_OperatingIncomeLoss
Sale of New Jersey net operating losses 269,127us-gaap_GainLossOnInvestments 0us-gaap_GainLossOnInvestments
Other expense, net (25,173)us-gaap_NonoperatingIncomeExpense (688)us-gaap_NonoperatingIncomeExpense
NET LOSS $ (10,221,045)us-gaap_NetIncomeLoss $ (3,713,127)us-gaap_NetIncomeLoss
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.32)us-gaap_EarningsPerShareBasicAndDiluted $ (0.20)us-gaap_EarningsPerShareBasicAndDiluted
WEIGHTED AVERAGE BASIC AND DILUTED NUMBER OF SHARES OUTSTANDING (in shares) 32,076,717us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 19,001,370us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted